Changes of pathogens for community-acquired pneumonia_West China Medical Journal

Authors：

 FAN Hong , SHEN Yongchun , TONG Xiang

Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding?author：

FAN Hong, Email: fanhongfan@qq.com

Keywords：

Community-acquired pneumonia; Pathogen; Change

DOI：

10.7507/1002-0179.201710136

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Community-acquired pneumonia (CAP) is still a common disease that seriously affects people’s health. It is of great clinical significance for proper anti-infective therapy to identify the characteristics and changes of the pathogens. Along with the accelerated process of aging population, increased use of immunosuppression agents, and increased morbidity of malignant tumor and underlying diseases, the pathogenic spectrum of patients with CAP varies as well. This article reviews the important pathogenic changes of CAP in recent years.

Citation： FAN Hong, SHEN Yongchun, TONG Xiang. Changes of pathogens for community-acquired pneumonia. West China Medical Journal, 2018, 33(1): 84-87. doi: 10.7507/1002-0179.201710136 Copy

1.	中華醫學會呼吸病學分會. 中國成人社區獲得性肺炎診斷和治療指南 (2016 年版). 中華結核和呼吸雜志, 2016, 39(4): 253-279.
2.	Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax, 2009, 64(Suppl 3): iii1-iii55.
3.	Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U. S. Adults. N Engl J Med, 2015, 373(5): 415-427.
4.	國家衛生和計劃生育委員會統計信息中心. 中國衛生和計劃生育統計年鑒. (2014-04-26)［2017-10-20］. http://www.nhfpc.gov. cn/htmlfiles/zwgkzt/ptjnj/year2013/index2013.html.
5.	Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet, 2015, 386(9998): 1097-1108.
6.	Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis, 2007, 44(Suppl 2): S27-S72.
7.	Boyles TH, Brink A, Calligaro GL, et al. South African guideline for the management of community-acquired pneumonia in adults. J Thorac Dis, 2017, 9(6): 1469-1502.
8.	Miyashita N, Matsushima T, Oka M. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med, 2006, 45(7): 419-428.
9.	Rozenbaum MH, Pechlivanoglou P, van der Werf T, et al. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis, 2013, 32(3): 305-316.
10.	Luna CM, Famiglietti A, Absi R, et al. Community-acquired pneumonia - etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest, 2000, 118(5): 1344-1354.
11.	Liu Y, Chen M, Zhao T, et al. Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population. BMC Infect Dis, 2009, 9: 31.
12.	Tao LL, Hu BJ, He LX, et al. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J (Engl), 2012, 125(17): 2967-2972.
13.	李群, 李為民, 高屬生, 等. 四川地區社區獲得性肺炎的病原學調查. 華西醫學, 2008, 23(2): 275-277.
14.	Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med, 2016, 37(6): 819-828.
15.	Marchello C, Dale AP, Thuy NT, et al. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a Meta-analysis. Ann Fam Med, 2016, 14(6): 552-566.
16.	劉又寧, 陳民鈞, 趙鐵梅, 等. 中國城市成人社區獲得性肺炎 665 例病原學多中心調查. 中華結核和呼吸雜志, 2006, 29(1): 3-8.
17.	熊祎虹, 鄧銳, 付榮榮, 等. 非典型病原菌致成人社區獲得性肺炎患者的臨床特點分析. 中華結核和呼吸雜志, 2010, 33(9): 646-650.
18.	Rocha NO, Leite RF, Baldi BG. Update on viral community-acquired pneumonia. Rev Assoc Med Bras, 2013, 59(1): 78-84.
19.	Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax, 2008, 63(1): 42-48.
20.	Charles PG, Whitby M, Fuller AJ, et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis, 2008, 46(10): 1513-1521.
21.	Alimi Y, Lim WS, Lansbury L, et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol, 2017, 95: 26-35.
22.	劉雅芬, 陳美芳, 高燕, 等. 北京地區成人社區獲得性肺炎病原學分析. 中華醫學雜志, 2013, 93(26): 2043-2047.
23.	鄧紫薇, 仇成鳳, 李茂作, 等. 成人社區獲得性肺炎主要病原體分布的 Meta 分析. 中國抗生素雜志, 2016, 41(12): 950-955.
24.	佘丹陽. 我國成人社區獲得性肺炎病原學與歐美國家的差異. 中華結核和呼吸雜志, 2015, 38(1): 13-15.
25.	趙爽, 鄧旺, 王導新, 等. 老年性社區獲得性肺炎病原菌及藥敏結果分析. 中華老年多器官疾病雜志, 2015, 14(3): 215-219.
26.	Cillóniz C, Civljak R, Nicolini A, et al. Polymicrobial community-acquired pneumonia: an emerging entity. Respirology, 2016, 21(1): 65-75.
27.	Burk M, El-Kersh K, Saad M, et al. Viral infection in community-acquired pneumonia: a systematic review and meta-analysis. Eur Respir Rev, 2016, 25(140): 178-188.
28.	Holter JC, Müller F, Bj?rang O, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis, 2015, 15: 64.
29.	Cillóniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax, 2011, 66(4): 340-346.
30.	徐毛治, 劉艷茹, 張青梅. 不同采樣技術對社區獲得性肺炎病原學的診斷價值. 國際呼吸雜志, 2009, 29(20): 1232-1233.
31.	劉策, 葉芳. 我國社區獲得性肺炎病原學分布特點. 中國醫藥導報, 2016, 13(15): 55-58.

1. 中華醫學會呼吸病學分會. 中國成人社區獲得性肺炎診斷和治療指南 (2016 年版). 中華結核和呼吸雜志, 2016, 39(4): 253-279.
2. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax, 2009, 64(Suppl 3): iii1-iii55.
3. Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U. S. Adults. N Engl J Med, 2015, 373(5): 415-427.
4. 國家衛生和計劃生育委員會統計信息中心. 中國衛生和計劃生育統計年鑒. (2014-04-26)［2017-10-20］. http://www.nhfpc.gov. cn/htmlfiles/zwgkzt/ptjnj/year2013/index2013.html.
5. Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet, 2015, 386(9998): 1097-1108.
6. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis, 2007, 44(Suppl 2): S27-S72.
7. Boyles TH, Brink A, Calligaro GL, et al. South African guideline for the management of community-acquired pneumonia in adults. J Thorac Dis, 2017, 9(6): 1469-1502.
8. Miyashita N, Matsushima T, Oka M. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med, 2006, 45(7): 419-428.
9. Rozenbaum MH, Pechlivanoglou P, van der Werf T, et al. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis, 2013, 32(3): 305-316.
10. Luna CM, Famiglietti A, Absi R, et al. Community-acquired pneumonia - etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest, 2000, 118(5): 1344-1354.
11. Liu Y, Chen M, Zhao T, et al. Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population. BMC Infect Dis, 2009, 9: 31.
12. Tao LL, Hu BJ, He LX, et al. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J (Engl), 2012, 125(17): 2967-2972.
13. 李群, 李為民, 高屬生, 等. 四川地區社區獲得性肺炎的病原學調查. 華西醫學, 2008, 23(2): 275-277.
14. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med, 2016, 37(6): 819-828.
15. Marchello C, Dale AP, Thuy NT, et al. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a Meta-analysis. Ann Fam Med, 2016, 14(6): 552-566.
16. 劉又寧, 陳民鈞, 趙鐵梅, 等. 中國城市成人社區獲得性肺炎 665 例病原學多中心調查. 中華結核和呼吸雜志, 2006, 29(1): 3-8.
17. 熊祎虹, 鄧銳, 付榮榮, 等. 非典型病原菌致成人社區獲得性肺炎患者的臨床特點分析. 中華結核和呼吸雜志, 2010, 33(9): 646-650.
18. Rocha NO, Leite RF, Baldi BG. Update on viral community-acquired pneumonia. Rev Assoc Med Bras, 2013, 59(1): 78-84.
19. Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax, 2008, 63(1): 42-48.
20. Charles PG, Whitby M, Fuller AJ, et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis, 2008, 46(10): 1513-1521.
21. Alimi Y, Lim WS, Lansbury L, et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol, 2017, 95: 26-35.
22. 劉雅芬, 陳美芳, 高燕, 等. 北京地區成人社區獲得性肺炎病原學分析. 中華醫學雜志, 2013, 93(26): 2043-2047.
23. 鄧紫薇, 仇成鳳, 李茂作, 等. 成人社區獲得性肺炎主要病原體分布的 Meta 分析. 中國抗生素雜志, 2016, 41(12): 950-955.
24. 佘丹陽. 我國成人社區獲得性肺炎病原學與歐美國家的差異. 中華結核和呼吸雜志, 2015, 38(1): 13-15.
25. 趙爽, 鄧旺, 王導新, 等. 老年性社區獲得性肺炎病原菌及藥敏結果分析. 中華老年多器官疾病雜志, 2015, 14(3): 215-219.
26. Cillóniz C, Civljak R, Nicolini A, et al. Polymicrobial community-acquired pneumonia: an emerging entity. Respirology, 2016, 21(1): 65-75.
27. Burk M, El-Kersh K, Saad M, et al. Viral infection in community-acquired pneumonia: a systematic review and meta-analysis. Eur Respir Rev, 2016, 25(140): 178-188.
28. Holter JC, Müller F, Bj?rang O, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis, 2015, 15: 64.
29. Cillóniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax, 2011, 66(4): 340-346.
30. 徐毛治, 劉艷茹, 張青梅. 不同采樣技術對社區獲得性肺炎病原學的診斷價值. 國際呼吸雜志, 2009, 29(20): 1232-1233.
31. 劉策, 葉芳. 我國社區獲得性肺炎病原學分布特點. 中國醫藥導報, 2016, 13(15): 55-58.

Previous Article
Diagnosis and management of pulmonary nodules
Next Article
Current status of diagnosis and treatment of viral pneumonia in adults

West China Medical Journal

Changes of pathogens for community-acquired pneumonia

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content